Advaxis Inc.
The Technology Centre of New Jersey
Suite 117 675 US Route 1
North Brunswick,
NJ 08902
United States - Map
Phone: 732-545-1590
Fax: 732-545-1084
Web Site: http://www.advaxis.com
| Advaxis, Inc., a development stage biotechnology company, engages in the research and development of new cancer-fighting techniques primarily in the United States. The company develops cancer vaccines targeting cervical, head and neck, breast, prostate, and other cancers. Its products in development stage includes ADXS11-001, a Phase I/II trial product to treat cervical intraepithelial neoplasia, cervical cancer, and head and neck cancer; ADXS31-142, a Phase I stage product for prostate cancer; and ADXS31-164, a Phase I stage product for breast cancer. The company was founded in 2002 and is based in North Brunswick, New Jersey. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Thomas A. Moore , 58
Chairman, Chief Exec. Officer and Member of Nominating & Corp. Governance Committee |
$
352.00K |
$
0 | Mr. Fredrick D. Cobb M.S., 61
Principal Financial Officer, Principal Accounting Officer, VP of Fin. and Assistant Sec. |
$
222.00K |
$
0 | Dr. John Rothman Ph.D., 60
Chief Operating Officer and Exec. VP of Clinical & Scientific Operations |
$
310.00K |
$
0 | Dr. James Patton M.D., 51
Medical Director, Director and Member of Audit Committee |
N/A
| N/A | Dr. Vafa Shahabi Ph.D.,
Director of R&D |
$
161.00K |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.48% Nasdaq 
0.01 (9.09%) 
Profile
